Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Major funding boost for research on neurodegenerative diseases

Brain Canada and the Canadian Institutes of Health Research congratulate Dr. Meaghan O'Reilly from Sunnybrook Research Institute and the University of Toronto as well as Dr. Liang Li based out of University of Alberta whose projects have been recommended for funding as part the 2022 European Union Joint Programme on Neurodegenerative Disease Research (JPND)'s initiative to find causes, develop cures and identify better ways to care for people with Alzheimer's, Parkinson's, Huntington's and other neurodegenerative diseases more rapidly.

16 Feb 2023

Social and economic disadvantage may explain the higher risk of dementia in women

A large international study of dementia risk involving almost 30,000 people from 18 countries covering all six continents suggests that social and economic disadvantage may explain the higher risk of the condition in women.

15 Feb 2023

Active compound in Lion’s Mane mushroom improves nerve growth and memory

Scientists report that the active compound from an edible mushroom, Hericium erinaceus, can enhance nerve growth and boost memory.

13 Feb 2023

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

In a recent study published in the Proceedings of the National Academy of Sciences, researchers assessed the capability of two small molecules of disintegrating alpha-synuclein fibrils.

13 Feb 2023

Fructose may be fueling the formation of Alzheimer’s disease

An ancient human foraging instinct, fueled by fructose production in the brain, may hold clues to the development and possible treatment of Alzheimer's disease (AD), according to researchers at the University of Colorado Anschutz Medical Campus.

13 Feb 2023

Active compound from edible mushrooms boosts nerve growth and enhances memory

Researchers from The University of Queensland have discovered the active compound from an edible mushroom that boosts nerve growth and enhances memory.

10 Feb 2023

Researchers discover new neurological condition characterized by issues with motor coordination and speech

Researchers at the National Institutes of Health have discovered a new neurological condition characterized by issues with motor coordination and speech. They report their findings in npj Genomic Medicine.

10 Feb 2023

Disruptions to the normal fllow of brain fluid linked to neurological conditions

The brain floats in a sea of fluid that cushions it against injury, supplies it with nutrients and carries away waste.

10 Feb 2023

Novel nuclear medicine imaging protocol cuts costs and radiation exposure for Alzheimer's patients

A novel nuclear medicine imaging protocol can take the place of two separate imaging scans for the evaluation of brain changes linked to cognitive impairment, cutting costs and radiation exposure for patients as well as providing them greater comfort.

8 Feb 2023

Changes in brain aerobic glycolysis reflect aging-related pathologies in Alzheimer’s

Researchers explore aerobic glycolysis in the brain and its resilience during Alzheimer's disease.

8 Feb 2023

Professor Sara Linse presents new data on protein interactions in Alzheimer’s disease using the Fluidity One-W at FEBS 2019

Fluidic Analytics’ diffusional sizing technology has been influential in a recent study that investigates protein binding and self-assembly in Alzheimer’s disease.

From Fluidic Analytics 8 Feb 2023

Expert work group examines and redefines “clinical meaningfulness” in Alzheimer’s

As the Alzheimer's disease scientific community, patients, and families seek to understand the results of clinical trials of new Alzheimer's treatments, the Alzheimer's Association convened an expert work group to discuss an important and timely issue: the "clinical meaningfulness" of results from these studies.

7 Feb 2023

What do gut microbiota have to do with Alzheimer's and dementia?

Researchers explore the preventive and therapeutic potential of gut microbiome modulation in the treatment of Alzheimer’s disease.

6 Feb 2023

Changes in the cerebral neural network could function as a biomarker for neurocognitive disorders

In many neurodegenerative conditions, brain changes occur before symptoms emerge. But now, researchers from Japan have found a new way to distinguish these conditions in the early stages according to changes in brain activity patterns.

6 Feb 2023

Researchers develop a cell line to address the challenges facing cellular modeling of disease

Bill Skarnes and team established and characterized a stable iPSC line, KOLF2.1J, to act as a high-quality baseline platform for modeling human disease.

3 Feb 2023

FSU psychologist wins NIA grant to treat anxiety in older adults with Alzheimer's, cognitive impairment

For the more than 6 million Americans living with Alzheimer's disease, related dementias, or mild cognitive impairment, anxiety is often an accompanying challenge.

3 Feb 2023

UC Davis launches new institute to advance basic knowledge of psychedelics and neurotherapeutics

The University of California, Davis has launched the Institute for Psychedelics and Neurotherapeutics to advance basic knowledge about the mechanisms of psychedelics and translate it into safe and effective treatments for diseases such as depression, post-traumatic stress disorder, addiction, Alzheimer's disease and Parkinson's disease, among others.

2 Feb 2023

Rutgers to launch a research and treatment center focused on Alzheimer's disease

Rutgers Biomedical and Health Sciences (RBHS) is launching the Herbert and Jacqueline Krieger Klein Alzheimer's and Dementia Clinical Research and Treatment Center.

1 Feb 2023

Study finds link between neurodegeneration in obese people and Alzheimer's disease

A new study led by scientists at The Neuro (Montreal Neurological Institute-Hospital) of McGill University finds a correlation between neurodegeneration in obese people and Alzheimer's disease (AD) patients, suggesting that losing excess weight could slow cognitive decline in aging and lower risk for AD.

31 Jan 2023

Setting new guidelines for innovative services to prevent Alzheimer's disease

Memory loss, behavioral changes, cognitive deficits: Alzheimer's disease leads to a dramatic loss of autonomy for those affected and has a heavy impact on health costs.

31 Jan 2023

Alzheimer's Disease News and Research

Further Reading

Major funding boost for research on neurodegenerative diseases

Social and economic disadvantage may explain the higher risk of dementia in women

Active compound in Lion’s Mane mushroom improves nerve growth and memory

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

Fructose may be fueling the formation of Alzheimer’s disease

Active compound from edible mushrooms boosts nerve growth and enhances memory

Researchers discover new neurological condition characterized by issues with motor coordination and speech

Disruptions to the normal fllow of brain fluid linked to neurological conditions

Novel nuclear medicine imaging protocol cuts costs and radiation exposure for Alzheimer's patients

Changes in brain aerobic glycolysis reflect aging-related pathologies in Alzheimer’s

Professor Sara Linse presents new data on protein interactions in Alzheimer’s disease using the Fluidity One-W at FEBS 2019

Expert work group examines and redefines “clinical meaningfulness” in Alzheimer’s

What do gut microbiota have to do with Alzheimer's and dementia?

Changes in the cerebral neural network could function as a biomarker for neurocognitive disorders

Researchers develop a cell line to address the challenges facing cellular modeling of disease

FSU psychologist wins NIA grant to treat anxiety in older adults with Alzheimer's, cognitive impairment

UC Davis launches new institute to advance basic knowledge of psychedelics and neurotherapeutics

Rutgers to launch a research and treatment center focused on Alzheimer's disease

Study finds link between neurodegeneration in obese people and Alzheimer's disease

Setting new guidelines for innovative services to prevent Alzheimer's disease

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News